Literature DB >> 1825635

Fc gamma RIII (CD16) on human macrophages is a functional product of the Fc gamma RIII-2 gene.

B Perussia1, J V Ravetch.   

Abstract

The low-affinity Fc receptor for immune-complexed IgG (Fc gamma RIII; CD16) present on in vitro cultured human monocytes are encoded by an Fc gamma RIII-2 gene that, by cDNA sequence analysis, is identical to that expressed on tissue macrophages and on natural killer cells. In macrophages, Fc gamma RIII-2 encodes a glycoprotein of 52-62 kDa, with a peptide backbone of 33 kDa identical to that of the homologous receptor on natural killer cells. Like this and unlike in polymorphonuclear neutrophils, Fc gamma RIII (CD16) on cultured monocytes is insensitive to phosphatidylinositol-specific phospholipase C, is not allelic for the neutrophil NA alloantigens NA-1/NA-2, is not recognized by a monoclonal antibody (1D3) detecting an epitope present only on neutrophil Fc gamma RIII (CD16) and functions to trigger cytotoxicity upon ligand binding.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825635     DOI: 10.1002/eji.1830210226

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  In the absence of other Fc receptors, Fc gamma RIIIA transmits a phagocytic signal that requires the cytoplasmic domain of its gamma subunit.

Authors:  J G Park; R E Isaacs; P Chien; A D Schreiber
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 2.  The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes.

Authors:  M J McConville; M A Ferguson
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

3.  Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells.

Authors:  Martin Felices; Todd R Lenvik; Zachary B Davis; Jeffrey S Miller; Daniel A Vallera
Journal:  Methods Mol Biol       Date:  2016

4.  Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.

Authors:  L A Sanders; R G Feldman; M M Voorhorst-Ogink; M de Haas; G T Rijkers; P J Capel; B J Zegers; J G van de Winkel
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Listeria monocytogenes phosphatidylinositol (PI)-specific phospholipase C has low activity on glycosyl-PI-anchored proteins.

Authors:  A J Gandhi; B Perussia; H Goldfine
Journal:  J Bacteriol       Date:  1993-12       Impact factor: 3.490

Review 6.  Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.

Authors:  Zachary B Davis; Daniel A Vallera; Jeffrey S Miller; Martin Felices
Journal:  Semin Immunol       Date:  2017-09-05       Impact factor: 11.130

7.  Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties.

Authors:  Jeffrey L Nordstrom; Sergey Gorlatov; Wenjun Zhang; Yinhua Yang; Ling Huang; Steve Burke; Hua Li; Valentina Ciccarone; Tengfei Zhang; Jeffrey Stavenhagen; Scott Koenig; Stanford J Stewart; Paul A Moore; Syd Johnson; Ezio Bonvini
Journal:  Breast Cancer Res       Date:  2011-11-30       Impact factor: 6.466

Review 8.  Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.

Authors:  Sarah Cooley; Peter Parham; Jeffrey S Miller
Journal:  Blood       Date:  2018-01-22       Impact factor: 25.476

9.  Reconstitution of human Fc gamma RIII cell type specificity in transgenic mice.

Authors:  M Li; U Wirthmueller; J V Ravetch
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Fractalkine preferentially mediates arrest and migration of CD16+ monocytes.

Authors:  Petronela Ancuta; Ravi Rao; Ashlee Moses; Andrew Mehle; Sunil K Shaw; F William Luscinskas; Dana Gabuzda
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.